A client undergoing a blood transfusion reports sudden onset urticaria, pruritus, and flushing.
What type of transfusion reaction is the client likely experiencing based on these symptoms?

Choice A rationale:

Oxygen therapy is not a medication used to promote clotting or stop bleeding.

Its primary purpose is to improve oxygen delivery to tissues, especially in cases of hypoxia.

Choice B rationale:

Erythropoietin injections are used to stimulate red blood cell production in conditions like anemia.

While it can indirectly help improve oxygen-carrying capacity, it does not promote clotting or stop bleeding.

Choice C rationale:

Hemostatic agents like vitamin K or tranexamic acid can help promote clotting and stop bleeding.

Vitamin K is essential for the synthesis of clotting factors in the liver, while tranexamic acid is an antifibrinolytic agent that prevents the breakdown of clots.

These medications are often used in bleeding disorders to control hemorrhage.

Choice D rationale:

Iron therapy is used to treat iron-deficiency anemia and increase hemoglobin levels.

It does not have a direct role in promoting clotting or stopping bleeding.

Choice A rationale:

Whole blood.

Rationale: Whole blood contains red blood cells, plasma, platelets, and clotting factors.

While it can increase fibrinogen levels, it also contains other components that may not be necessary for a patient with hemophilia A.

Fresh frozen plasma (FFP) is a more specific choice for increasing fibrinogen levels.

Choice B rationale:

Packed red blood cells (PRBCs)

Rationale: PRBCs primarily consist of red blood cells and are not a suitable choice for increasing fibrinogen levels.

Hemophilia A is a clotting disorder, and fibrinogen is a clotting factor found in plasma.

PRBCs do not contain significant amounts of plasma or clotting factors.

Choice C rationale:

Fresh frozen plasma (FFP)

Rationale: FFP is the most suitable choice for increasing fibrinogen levels in a patient with hemophilia A.

FFP contains all the clotting factors, including fibrinogen, and can help correct coagulation abnormalities in these patients.

Choice D rationale:

Platelets.

Rationale: Platelets are involved in the clotting process, but they do not contain significant amounts of fibrinogen.

Platelets are used to treat conditions where there is a deficiency in platelet count or function, not to increase fibrinogen levels.